Company: CMND
Filing Date: 2025-11-17
Form Type: 424B5
Source: 0001213900-25-111233
Chunk: 36

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-17
Form: 424B5
Chunk 36
---
 Factors                                    |     |  6 |
| Offer Statistics and Expected Timetable         |     |  6 |
| Forward-Looking Statements                      |     |  7 |
| Capitalization                                  |     |  9 |
| Use of Proceeds                                 |     |  9 |
| Description of Share Capital                    |     | 10 |
| Description of Subscription Rights              |     | 21 |
| Description of Warrants                         |     | 22 |
| Description of Units                            |     | 24 |
| Taxation                                        |     | 24 |
| Plan of Distribution                            |     | 24 |
| Legal Matters                                   |     | 28 |
| Experts                                         |     | 28 |
| Where You Can Find More Information             |     | 28 |
| Incorporation of Certain Documents by Reference |     | 29 |
| Enforceability of Civil Liabilities             |     | 30 |
| Expenses                                        |     | 30 |

<div align='center'>i

ABOUT THIS PROSPECTUS</div>

This prospectus is part of a Registration Statement on Form F-3 that we filed with the Securities and Exchange Commission, or the SEC, utilizing a “shelf” registration process. Under this shelf registration process, we may sell our securities described in this prospectus in one or more offerings up to a total dollar amount of $50,000,000. This prospectus does not contain all of the information set forth in the registration statement, certain parts of which are omitted in accordance with the rules and regulations of the SEC. Accordingly, you should refer to the registration statement and its exhibits for further information about us and our securities. Copies of the registration statement and its exhibits are on file with the SEC. Statements contained in this prospectus concerning the documents we have filed with the SEC are not intended to be comprehensive, and in each instance we refer you to a copy of the actual document filed as an exhibit to the registration statement or otherwise filed with the SEC.

Each time we offer our securities, we will provide you with a prospectus supplement that will describe the specific amounts, prices and terms of the securities we offer. The prospectus supplement may also add, update or change information contained in this prospectus. This prospectus, together with applicable prospectus supplements and the documents incorporated by reference in this prospectus and any prospectus supplements, includes all material information relating to this offering. Please read carefully both this prospectus and any prospectus supplement together with additional information described below